Go to ...

Nordens Ekonomi Norge

RSS Feed

17. oktober 2018

Auris Medical to provide update on intranasal betahistine program on Wednesday, October 17, 2018


Euroinvestor.com A/S Euroinvestor.com A/S


Zug, Switzerland, October 12, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental health supportive care, today announced that it will provide an upda..

More Stories From

Do NOT follow this link or you will be banned from the site!
Read previous post:
Market Trends Toward New Normal in Antero Resources, SunPower, The Clorox, CECO Environmental, Fortinet, and Pure Storage — Emerging Consolidated Expectations, Analyst Ratings

NEW YORK, Oct. 12, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released...

Close